PERSPECTA

News from every angle

Back to headlines

Sangamo Therapeutics Stock Delisted from Nasdaq, Moves to OTCQB

Sangamo Therapeutics (SGMO) has been delisted from the Nasdaq exchange, with its stock now trading on the OTCQB market.

29 Apr, 14:45 — 29 Apr, 14:45
PostShare

Sources

Showing 1 of 1 sources